Science


How Not to Do Ibogaine 101 with Juliana Mulligan | Part 8


The Ibogaine Conversation Part 8 | This is not a do-it-at-home type thing.

Former Underground Provider, Dimitri Mugianis, on the Regulation of Ibogaine | Part 7


The Ibogaine Conversation Part 7 | "Prescription is not about accessibility, by definition it’s about restriction. Unless we start to use psychedelics as a way to tear apart these structures and build new ones in their place, then I think it's all a revolving door."

Patrick Kroupa, hacker and ex-heroin ‘junkie’, on microdosing and the medicalization of ibogaine | Part 6


The Ibogaine Conversation Part 6 | My experience with heroin went from age 14 up to age 30, and taking ibogaine was as close to a miracle as I have ever experienced in my life.

Talking Ibogaine Research for Opioid Addiction with Thomas Kingsley Brown | Part 5


The Ibogaine Conversation Part 5 | Thomas Kingsley Brown, PhD, studied the long-term outcomes of people who received ibogaine for the treatment of opioid addiction. We talked about the results.

We are Bwitists and Healers in Gabon. Here’s What We Think of the Global Interest in Iboga. | Part 4


The Ibogaine Conversation Part 4 | The Western world cannot receive the benefits of iboga if they don’t try to understand and assimilate the traditional approach.

How has Western influence changed the traditional use of iboga in Gabon? | Part 3


The Ibogaine Conversation Part 3 | What is the authentic Bwiti tradition? The answer I got was that this idea of authenticity is an odd idea. It’s a very Western idea. Bwiti considers itself as a culture that’s changing.

Taking Iboga with the People of Gabon | Part 2


The Ibogaine Conversation Part 2 | Our first stop is in Gabon, Africa, where consumption of the iboga root bark is intimately tied to the ancient spiritual discipline known as Bwiti.

Ibogaine presents unique challenges in how we approach harm reduction and treat addiction | Part 1


The Ibogaine Conversation Part 1 | This series explores the unique challenges ibogaine presents in how we approach plant medicine, harm reduction, and treatment for addiction, through the lens of ibogaine researchers, providers, patients, and advocates from around the world.

Johns Hopkins studying effects of psilocybin on brains of long-term meditators


Are these states really similar? Many meditators have answered quite clearly, yes.

Could Oregon be the First State to Legalize Psilocybin Therapy?


A group in Oregon is drafting a ballot initiative for 2020 that would allow individuals to take psilocybin in supervised settings.

The State: The Opioid Epidemic


For anyone who remembers the Reagan Administration's awesome response to the '80s crack epidemic, the Trump plan may prompt discouraging deja vu.

Your Brain on Psychedelic Drugs


What is it about psychedelics that has the power to change lives for the better? The answer might lie in the unique ways that psychedelics interact with the brain.

Psychedelics and Mental Health


Depression. Anxiety. Addiction. Most everyone of us knows somebody who is battling such a condition. Talk therapies may help, but sometimes they don’t. Antidepressants may help, but sometimes they don’t. Some patients are of the opinion that antidepressants are like “Band-Aids” in the way that they never really tackle the underlying issues of their problems.

What’s so controversial about microdosing?


The incredible mainstream press microdosing has received has managed to avoid many discussions.

I was in the MAPS MDMA for PTSD study. It freed me from a childhood of abuse.


MDMA-assisted psychotherapy gave me the ability to feel compassion and empathy for myself.

Breathe. Breathe. Breathe. An Interview with Iker Puente on Holotropic Breathwork


Holotropic Breathwork is not just a breath technique. It was conceived as a non-drug way of accessing non-ordinary states of consciousness.

How Psychedelic Science Privileges Some, Neglects Others, and Limits Us All


There is an urgent need for cultural humility in psychedelic science in order to prevent it from falling into the same limiting, and often unethical, traps that we see in Western science and medicine.

Psychedelic cluster busting headache medication saves me. And it’s completely illegal


Cluster headaches to me feel like someone has my eyeball in their fist, steadily putting more and more pressure on it until it threatens to pop like a grape.

Meet the professor who self-administered 73 high-dose LSD sessions


I chose to learn Grof’s methods for working therapeutically with LSD and use them in my private life to systematically explore my own mind and the mind of the universe as deeply as possible—73 high-dose sessions over 20 years.

Of Molecules and Minds: The Science of Ayahuasca


There’s a beauty and sense of wonder that comes from knowing how the world works, and the nature of the psychedelic experience dovetails almost perfectly with that awareness.

Science


How Not to Do Ibogaine 101 with Juliana Mulligan | Part 8


The Ibogaine Conversation Part 8 | This is not a do-it-at-home type thing.

Former Underground Provider, Dimitri Mugianis, on the Regulation of Ibogaine | Part 7


The Ibogaine Conversation Part 7 | "Prescription is not about accessibility, by definition it’s about restriction. Unless we start to use psychedelics as a way to tear apart these structures and build new ones in their place, then I think it's all a revolving door."

Patrick Kroupa, hacker and ex-heroin ‘junkie’, on microdosing and the medicalization of ibogaine | Part 6


The Ibogaine Conversation Part 6 | My experience with heroin went from age 14 up to age 30, and taking ibogaine was as close to a miracle as I have ever experienced in my life.

Talking Ibogaine Research for Opioid Addiction with Thomas Kingsley Brown | Part 5


The Ibogaine Conversation Part 5 | Thomas Kingsley Brown, PhD, studied the long-term outcomes of people who received ibogaine for the treatment of opioid addiction. We talked about the results.

We are Bwitists and Healers in Gabon. Here’s What We Think of the Global Interest in Iboga. | Part 4


The Ibogaine Conversation Part 4 | The Western world cannot receive the benefits of iboga if they don’t try to understand and assimilate the traditional approach.

How has Western influence changed the traditional use of iboga in Gabon? | Part 3


The Ibogaine Conversation Part 3 | What is the authentic Bwiti tradition? The answer I got was that this idea of authenticity is an odd idea. It’s a very Western idea. Bwiti considers itself as a culture that’s changing.

Taking Iboga with the People of Gabon | Part 2


The Ibogaine Conversation Part 2 | Our first stop is in Gabon, Africa, where consumption of the iboga root bark is intimately tied to the ancient spiritual discipline known as Bwiti.

Ibogaine presents unique challenges in how we approach harm reduction and treat addiction | Part 1


The Ibogaine Conversation Part 1 | This series explores the unique challenges ibogaine presents in how we approach plant medicine, harm reduction, and treatment for addiction, through the lens of ibogaine researchers, providers, patients, and advocates from around the world.

Johns Hopkins studying effects of psilocybin on brains of long-term meditators


Are these states really similar? Many meditators have answered quite clearly, yes.

Could Oregon be the First State to Legalize Psilocybin Therapy?


A group in Oregon is drafting a ballot initiative for 2020 that would allow individuals to take psilocybin in supervised settings.

The State: The Opioid Epidemic


For anyone who remembers the Reagan Administration's awesome response to the '80s crack epidemic, the Trump plan may prompt discouraging deja vu.

Your Brain on Psychedelic Drugs


What is it about psychedelics that has the power to change lives for the better? The answer might lie in the unique ways that psychedelics interact with the brain.

Psychedelics and Mental Health


Depression. Anxiety. Addiction. Most everyone of us knows somebody who is battling such a condition. Talk therapies may help, but sometimes they don’t. Antidepressants may help, but sometimes they don’t. Some patients are of the opinion that antidepressants are like “Band-Aids” in the way that they never really tackle the underlying issues of their problems.

What’s so controversial about microdosing?


The incredible mainstream press microdosing has received has managed to avoid many discussions.

I was in the MAPS MDMA for PTSD study. It freed me from a childhood of abuse.


MDMA-assisted psychotherapy gave me the ability to feel compassion and empathy for myself.

Breathe. Breathe. Breathe. An Interview with Iker Puente on Holotropic Breathwork


Holotropic Breathwork is not just a breath technique. It was conceived as a non-drug way of accessing non-ordinary states of consciousness.

How Psychedelic Science Privileges Some, Neglects Others, and Limits Us All


There is an urgent need for cultural humility in psychedelic science in order to prevent it from falling into the same limiting, and often unethical, traps that we see in Western science and medicine.

Psychedelic cluster busting headache medication saves me. And it’s completely illegal


Cluster headaches to me feel like someone has my eyeball in their fist, steadily putting more and more pressure on it until it threatens to pop like a grape.

Meet the professor who self-administered 73 high-dose LSD sessions


I chose to learn Grof’s methods for working therapeutically with LSD and use them in my private life to systematically explore my own mind and the mind of the universe as deeply as possible—73 high-dose sessions over 20 years.

Of Molecules and Minds: The Science of Ayahuasca


There’s a beauty and sense of wonder that comes from knowing how the world works, and the nature of the psychedelic experience dovetails almost perfectly with that awareness.

Psymposia is a 501(c)(3) research non-profit with a mission to educate the public on psychedelic science and harm reduction.

Privacy Terms of Use

shiftnav-1